Exagen Inc.
XGNNASDAQHealthcareDiagnostics & Research
As of Oct 16, 2026 close
- Market cap
- $206.85M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.59$12.23
- Volume (live)
- -
- Avg. volume (3M)
- 325.81K
Exagen (XGN) Stock Price & Financial Analysis
Exagen Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $7.30 - $8.55 |
|---|---|
| 52-Week High | $12.23 |
| 52-Week Low | $2.59 |
| Open | $8.46 |
| Volume (last close) | 965.81K |
| Average Volume (3M) | 325.81K |
| Revenue (TTM) | 71.12M |
|---|---|
| Net Income (TTM) | -18.92M |
| Free Cash Flow (TTM) | -7.59M |
| EPS (TTM) | −$0.82 |
| Profit Margin | -26.61% |
| Operating Margin | -18.58% |
| Return on Equity (ROE) | -154.90% |
| Debt to Equity | 1.87 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 206.85M |
|---|---|
| Shares Outstanding | 24.16M |
| Price to Sales (P/S) | 2.91 |
| Price to Book (P/B) | 16.93 |
| EV/EBITDA | -18.32 |
| 50-Day MA | $7.66 |
|---|---|
| 200-Day MA | $4.91 |
| 1-Year Change | −25.82% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Exagen at a Glance
As of the Oct 16, 2026 close, Exagen (XGN) has a market capitalization of $206.85M. The stock trades at 2.9× sales. Over the trailing twelve months it lost $18.92M on revenue of $71.12M and burned $7.59M of free cash flow. Revenue grew 20.8% year over year.
As of its latest reported balance sheet, it holds $24.59M in cash and securities against $22.84M of debt, a net cash position of $1.75M.
Exagen does not currently pay a dividend.
The share price is down 25.8% over the past year. At $7.72 (the Oct 16, 2026 close) it sits within its 52-week range of $2.59 to $12.23, above its 200-day moving average of $4.91.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $10.20, 32.1% above the Oct 16, 2026 close.
Frequently Asked Questions About Exagen
What is the current stock price for XGN?
As of the Oct 16, 2026 close, XGN stock trades at $7.72. The 52-week range is $2.59–$12.23, with a day range of $7.30–$8.55.
What is the P/E ratio for XGN?
The P/E ratio (Price-to-Earnings) for XGN is shown in the Key Statistics section. This valuation metric helps compare Exagen Inc. to industry peers.
Does XGN pay dividends?
Exagen does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for XGN?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for XGN is Buy. The average 12-month price target is $10.20, a 32.1% upside from the Oct 16, 2026 close of $7.72.
What is the market cap of XGN?
As of the Oct 16, 2026 close, Exagen's market capitalization is $186.6M, classifying it as a micro-cap company. Exagen operates in the Healthcare sector within the Diagnostics & Research industry.